title: The nimorazole regimen in patients with head and neck cancer can increase the effect of vitamin K antagonists.
authors.forename: Nina H
authors.initials: NH
authors.lastname: Bjarnason
authors.forename: Michael
authors.initials: M
authors.lastname: Christiansen
authors.forename: Lena
authors.initials: L
authors.lastname: Specht
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004347:Drug Interactions; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D005931:Glottis; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D007012:Hypopharyngeal Neoplasms / Q000188:drug therapy; D019934:International Normalized Ratio; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008297:Male; D009554:Nimorazole / Q000494:pharmacology / Q000627:therapeutic use*; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D014812:Vitamin K; D009554:Nimorazole